Catalyst Pharmaceuticals Completes the Acquisition of U.S. Rights to FYCOMPA® (Perampanel) CIII
Source:
Nasdaq GlobeNewswire
/
25 Jan 2023 07:03:00 America/Chicago
N/A
Share on,